Immunotherapy: ALLOGENEIC T-CELL IMMUNOTHERAPY (CE-VST01-JC) FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) USING A HLA-DEFINED PEPTIDE PLATFORM

Gaëtan Thomas, Rajiv Khanna, Simon R. Best et al.|Cytotherapy|2023

Cited by 0